We found that adding higher levels of NRG1 intraventricularly promotes AD pathology, while blocking NRG1 signaling with GlyB4 induces morphologic changes in microglia associated with reduced plaque formation and synaptic loss. This evidence concerns the gene NRG1 and Alzheimer disease.